You are here

Article info

Article menu
XML
Multiple sclerosis
Research paper
Efficacy and safety of natalizumab in multiple sclerosis: interim observational programme results

Authors

  1. Correspondence to Dr H Butzkueven, Department of Medicine, Royal Melbourne Hospital Brain Centre, University of Melbourne, Level 4 East, Royal Melbourne Hospital Campus, Grattan Street, Parkville, Melbourne, VIC 3050, Australia; butz{at}unimelb.edu.au
View Full Text

Citation

Butzkueven H, Kappos L, Pellegrini F, et al
Efficacy and safety of natalizumab in multiple sclerosis: interim observational programme results
Journal of Neurology, Neurosurgery & Psychiatry 2014;85:1190-1197.

Publication history

  • Received October 3, 2013
  • Revised December 20, 2013
  • Accepted December 27, 2013
  • First published February 14, 2014.
Online issue publication 
October 17, 2014

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

    Files in this Data Supplement:

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 3.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/3.0/